Thus, the current study was to investigate the possible role of CDK5 in the tumorigenesis and aggressiveness of glioma and emphasized the relationship of CDK5 expression with Ki-67 labeling index (LI), which represents the status of tumor cell proliferation. This evidence concerns the gene CDK5 and central nervous system cancer.